COVID-19 in people living with human immunodeficiency virus: A case series of 33 patients [not peer reviewed]

Zotero / K4D COVID-19 Health Evidence Summaries Group / Top-Level Items 2020-05-05

Type Journal Article Author Georg Haerter Author Christoph D. Spinner Author Julia Roider Author Markus Bickel Author Ivanka Krznaric Author Stephan Grunwald Author Farhad Schabaz Author Daniel Gillor Author Nils Postel Author Matthias C. Mueller Author Markus Mueller Author Katja Roemer Author Knud Schewe Author Christian Hoffmann URL https://www.medrxiv.org/content/10.1101/2020.04.28.20073767v1 Rights © 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission. Pages 2020.04.28.20073767 Publication medRxiv The Preprint Server for Health Sciences Date 01/05/2020 Extra Publisher: Cold Spring Harbor Laboratory Press DOI 10.1101/2020.04.28.20073767 Accessed 2020-05-05 20:33:00 Library Catalog www.medrxiv.org Language en Abstract

Data on people living with human immunodeficiency virus (PLWH) in the current SARS-CoV-2 pandemic is still scarce. This case series of 33 PLWH patients with COVID-19 reveals symptoms and outcome in this special population. Three out of 32 patients with documented outcome died (9%). However, 91% of the patients recovered and 76% have been classified as mild cases, indicating that there is no excess morbidity and mortality among PLWH with symptomatic COVID-19. All patients were on antiretroviral treatment, of them 22 on tenofovir-containing regimen, and 4 on the protease inhibitor darunavir.

Short Title COVID-19 in people living with human immunodeficiency virus